| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |